1. Home
  2. VFF vs MGNX Comparison

VFF vs MGNX Comparison

Compare VFF & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Village Farms International Inc.

VFF

Village Farms International Inc.

HOLD

Current Price

$1.99

Market Cap

230.2M

Sector

N/A

ML Signal

HOLD

Logo MacroGenics Inc.

MGNX

MacroGenics Inc.

HOLD

Current Price

$4.50

Market Cap

220.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFF
MGNX
Founded
1989
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.2M
220.6M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
VFF
MGNX
Price
$1.99
$4.50
Analyst Decision
Buy
Buy
Analyst Count
1
5
Target Price
N/A
$5.00
AVG Volume (30 Days)
1.1M
1.3M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
184.38
N/A
EPS
0.02
N/A
Revenue
$215,937,000.00
$149,500,000.00
Revenue This Year
$12.19
N/A
Revenue Next Year
$15.82
$3.19
P/E Ratio
$99.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$1.30
52 Week High
$4.99
$5.08

Technical Indicators

Market Signals
Indicator
VFF
MGNX
Relative Strength Index (RSI) 42.53 52.72
Support Level $1.81 $1.49
Resistance Level $2.10 $4.55
Average True Range (ATR) 0.10 0.36
MACD 0.03 -0.02
Stochastic Oscillator 61.02 46.64

Price Performance

Historical Comparison
VFF
MGNX

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.

About MGNX MacroGenics Inc.

Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conjugates (ADCs) and multi-specific antibodies (which it refers to as DART and TRIDENT molecules). It is advancing three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload. Its segment is developing and commercializing monoclonal antibody-based therapeutics.

Share on Social Networks: